Injective's LI.FI Integration Boosts Cross-Chain Access

Injective's recent integration with LI.FI has significantly boosted cross-chain access for its users, expanding connectivity to over 60 different blockchains and more than 1,000 applications.

The DeFi-focused blockchain protocol aims to streamline cross-chain liquidity and bridging, making it easier for users to move assets between networks without the need for multiple bridges or fragmented liquidity sources.

Currently trading at $4.53 with a 24-hour trading volume of $70.28 million and a market capitalization of $453.8 million, Injective's price action has been closely monitored by traders as it reenters its previous trading range and eyes a potential bullish reversal.

The integration with LI.FI may further support Injective's positioning in the DeFi sector by making cross-chain movements more efficient for end users, which could ultimately contribute to stronger liquidity patterns over the long term.